Literature DB >> 9610037

Acute vision loss resulting from complications of ethanol abuse.

M Shimozono1, J C Townsend, P F Ilsen, D C Bright.   

Abstract

BACKGROUND: Alcoholism affects about 10% of men and 3% to 5% of women in their lifetime. It is a primary chronic disease with genetic, psychosocial, and environmental factors that influence its development and manifestations.
METHODS: A 47-year-old alcoholic male manifested mild nutritional optic atrophy, chronic anemia, pancreatitis, and previous gastrojejunostomy and pancreaticojejunostomy. After an acute episode of hypovolemic blood loss from peptic ulceration, there was increased bi-temporal optic nerve head pallor with permanent vision loss, central scotoma, and an acquired red-green color vision defect.
RESULTS: The genetic, psychosocial, and systemic effects of ethanol abuse--including anemia, cardiomyopathy, gastric/duodenal ulceration, pancreatitis, and neurologic deficits--are reviewed. Appropriate treatment and management of ocular manifestations and complications from alcoholism are discussed. Prophylactic topical therapy may be indicated to restore the balance between intraocular tension and optic nerve head perfusion in an attempt to prevent further axonal loss.
CONCLUSION: Alcohol-induced nutritional optic neuropathy should not be viewed as an isolated ocular entity, but rather as a potentially treatable neurologic problem. An interdisciplinary approach is essential optimal in the management of the alcoholic patient.

Entities:  

Mesh:

Year:  1998        PMID: 9610037

Source DB:  PubMed          Journal:  J Am Optom Assoc        ISSN: 0003-0244


  2 in total

Review 1.  Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review.

Authors:  John C M Brust
Journal:  Int J Environ Res Public Health       Date:  2010-04-04       Impact factor: 3.390

2.  An evaluation of genetic causes and environmental risks for bilateral optic atrophy.

Authors:  Andrew T Chen; Lauren Brady; Dennis E Bulman; Arun N E Sundaram; Amadeo R Rodriguez; Edward Margolin; John S Waye; Mark A Tarnopolsky
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.